Displaying 1 to 20 of 38 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | 1 Aug 2008 | N/A Active |
|
|
|
Aerie Pharmaceuticals Inc |
United States | 1 Mar 2011 | Series B Active |
|
|
|
Aerovance Inc |
United States | 1 Mar 2007 | Series C Initial investment. Round participant. Active |
|
|
|
Aerovance Inc |
United States | 1 Apr 2009 | N/A Active |
|
|
|
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. |
United States | 1 Apr 2008 | N/A |
|
|
|
Biolex Therapeutics Inc |
United States | 1 Oct 2008 | Series D Active |
|
|
|
Catabasis Pharmaceuticals Inc |
United States | 1 Apr 2010 | Series A |
|
|
|
Catabasis Pharmaceuticals Inc |
United States | 1 Dec 2011 | Series A |
|
|
|
Cellerant Therapeutics Inc Biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. |
United States | N/A |
||
|
|
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 1 Oct 2011 | Series A Active |
|
|
|
CoMentis Inc |
United States | N/A |
||
|
|
Delenex Therapeutics AG |
Switzerland | N/A |
||
|
|
Edev |
United States | N/A |
||
|
|
ESBATech AG Switzerland based Biomedical Research Unit of Alcon |
Switzerland | 1 Aug 2008 | Series B Initial investment. Round participant. Active |
|
|
|
ESBATech AG Switzerland based Biomedical Research Unit of Alcon |
Switzerland | 1 Aug 2006 | Series B Initial investment. Round participant. Active |
|
|
|
FerroKin Biosciences Inc A clinical stage biotechnology company dedicated to improving the management of patients with iron overload. |
United States | N/A |
||
|
|
Flowonix Medical A medical device company dedicated to helping those who suffer from chronic disorders. |
United States | 1 May 2012 | N/A |
|
|
|
Globus Medical Inc A medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. |
United States | 1 Aug 2007 | Series E |
|
|
|
Heptares Therapeutics Ltd |
United Kingdom | 1 Feb 2009 | Series A |
|
|
|
Link Medicine Inc Advancing disease-modifying technologies targeted at Alzheimer's, Parkinson's and other neurodegenerative diseases |
United States | 1 Sep 2008 | Series C |